跳至主要内容
临床试验/ACTRN12616000470493
ACTRN12616000470493已完成不适用

A randomised controlled trial investigating Inhalation of heated, humidified air against placebo in people with the common cold: a feasibility study

Fisher & Paykel Healthcare0 个研究点目标入组 30 人开始时间: 2016年4月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Jackson score greater than or equal to 5
  • 2. Symptoms have been present for less than 48 hours at time of randomisation

排除标准

  • 1. Age <16 years or >75 years
  • 2. Immunocompromised condition:
  • - Conditions causing immunosuppression e.g. HIV/AIDS, active cancer
  • - Currently prescribed steroids or other immunosuppressant medication
  • 3. A diagnosis of asthma, COPD or other significant respiratory conditions
  • 4. Nasal conditions such as deviated septum, chronic rhinitis, which, in the evaluation by the investigator, could impair nasal breathing.
  • 5. Use of cold remedies e.g. decongestants/cough linctus/sore throat lozenges within 6 hours of randomisation.
  • 6. Current use of antibiotics, steroids or inhaled medications.
  • 7. The investigator believes the participant or their care giver will be unable to safely use the myAIRVO 2 device following discharge
  • 8. Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

研究者

相似试验